Prognostic Value of a Novel Parameter in Patients with Infective Endocarditis

Table 1

Clinical characteristics of the study population.

Variable	Nonsurvivor group ()	Survivor group ()	value
Age (years)			0.044
Gender (male, )	16 (80.0%)	86 (67.7%)	0.271
WBC (×10^9/L)			0.004
Lymphocyte (×10^9/L)			0.131
Neutrophil (×10^9/L)			0.002
LWR			0.001
HB (g/L)			0.415
PLT (×10^9/L)			0.319
ALT	22.7 (3.9, 2433.3)	24.1 (3.0, 280.2)	0.468
AST	27.5 (13.7, 3654.2)	24.2 (9.1, 218.6)	0.360
ALP			0.058
GGT	42.9 (13.90, 216.40)	46.3 (11.10, 598.20)	0.769
LDH	332 (212.00, 2536.00)	292 (128.00, 644.00)	0.010
CK	48 (13.00, 742.00)	28 (6.00, 523.00)	0.002
UREA			0.002
CREA	83.8 (50.7, 902.0)	69.7 (37.1, 944.2)	0.028
LDH/LY	232.85 (65.19, 3092.68)	416.98 (56.06, 2340.00)	0.001
L-LWR	39.90 (11.81, 418.92)	20.71 (3.51, 265.91)	<0.001
Etiology
Staphylococcus, (%)	1 (5.00%)	11 (8.67%)	0.581
Streptococcus, (%)	6 (30.00%)	24 (18.90%)	0.255
Others, (%)	1 (5.00%)	8 (6.30%)	0.823
Culture negative, (%)	12 (60.00%)	84 (66.14%)	0.595
Surgery (%)	40.00%	81.11%	<0.001

ALP: alkaline phosphatase; ALT: alanine aminotransferase; AST: aspartate aminotransferase; CK: creatine kinase; CREA: creatinine; GGT: glutamyl transpeptidase; HB: hemoglobin; LDH: lactate dehydrogenase; LWR: lymphocyte-to-white blood cell ratio; L-LWR: LDH-to LWR; PLT: platelet; UREA: urea nitrogen; WBC: white blood cell.